Figure 6 | Scientific Reports

Figure 6

From: A novel retinoic acid drug, EYE-502, inhibits choroidal neovascularization by targeting endothelial cells and pericytes

Figure 6

Prediction the target genes of EYE-502. (A) 79 genes were predicted as the target genes of EYE-502 for CNV treatment. (B) PPI was conducted to obtain the interaction relationship between the target proteins. (C) GO enrichment analysis was conducted to obtain the top ten biological processes, cellular components, and molecular functions of the target genes of EYE-502. (D) KEGG enrichment analysis was conducted to obtain the top ten pathways of the target genes of EYE-502.

Back to article page